Access-Power & Co., Inc. (ACCR) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
ACCR representa a Access-Power & Co., Inc., una empresa del sector Communication Services con un precio de $ (capitalización de mercado 0). La acción obtiene una puntuación de 61/100, una calificación moderada basada en 9 KPI cuantitativos.
Ultimo analisis: 16 mar 2026Access-Power & Co., Inc. (ACCR) Perfil de Medios y Comunicaciones
Access-Power & Co., Inc. focuses on manufacturing and distributing medical marijuana clones and related products. Operating under brands like Clones By Drones and Clones by Cars, the company also ventures into pet calming products. Its small size and OTC market presence differentiate it within the telecommunications services sector.
Tesis de Inversión
Investing in Access-Power & Co., Inc. presents a high-risk, high-reward scenario given its presence in the volatile OTC market and the evolving cannabis industry. The company's negative P/E ratio of -3.08 and a negative profit margin of -14.1% indicate financial challenges. However, a gross margin of 59.0% suggests potential profitability if operational efficiencies improve. Growth catalysts include expansion of its Clones By Drones and Clones by Cars brands and increased adoption of its pet calming products. The company's beta of 3.05 indicates high volatility, reflecting the speculative nature of the stock.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market capitalization of $0.00B indicates a micro-cap company with limited financial resources.
- P/E ratio of -3.08 reflects current unprofitability, requiring careful monitoring of future earnings potential.
- Gross margin of 59.0% suggests a strong potential for profitability if sales volume increases and operational costs are managed effectively.
- Beta of 3.05 indicates high volatility compared to the market, making it a higher-risk investment.
- The company operates with only 1 employee, highlighting its small scale and potential operational constraints.
Competidores y Pares
Fortalezas
- Niche market focus on medical marijuana clones.
- Established brand names (Clones By Drones, Clones By Cars).
- Online platform for pet calming products (mycbdpets.com).
Debilidades
- Small scale of operations (1 employee).
- Limited financial resources (market cap of $0.00B).
- Negative profitability (negative P/E and profit margin).
Catalizadores
- Ongoing: Expansion of the Clones By Drones and Clones by Cars brands through increased distribution and marketing efforts.
- Ongoing: Growing demand for calming pet products, driving increased sales through the mycbdpets.com platform.
- Upcoming: Potential regulatory changes in the cannabis industry that could create new market opportunities.
- Upcoming: Strategic partnerships with established cannabis companies to expand market reach and access new technologies.
- Ongoing: Development of new cannabis-based products to diversify the company's product line.
Riesgos
- Potential: Regulatory changes in the cannabis industry that could restrict or prohibit the company's operations.
- Ongoing: Intense competition from larger cannabis companies with greater financial resources.
- Potential: Fluctuations in the price of cannabis, impacting the company's profitability.
- Ongoing: Limited financial resources and small scale of operations, hindering the company's ability to compete effectively.
- Potential: Low liquidity and trading volume of the stock, making it difficult to exit positions.
Oportunidades de crecimiento
- Expansion of Clones By Drones and Clones by Cars: The company can increase its market share by expanding the distribution network for its marijuana clone products. This involves targeting new geographic markets and establishing partnerships with dispensaries and growers. The legal cannabis market is projected to reach $42.9 billion by 2027, providing a substantial growth opportunity for clone providers. Timeline: Ongoing.
- Increased Adoption of Calming Pet Products: The market for pet calming products is growing as pet owners seek natural remedies for anxiety and stress in animals. Access-Power & Co., Inc. can capitalize on this trend by expanding its mycbdpets.com platform and introducing new product offerings. The pet CBD market is expected to reach $2.5 billion by 2028. Timeline: Ongoing.
- Strategic Partnerships: Forming strategic alliances with established players in the cannabis industry can provide Access-Power & Co., Inc. with access to new markets, technologies, and resources. This includes partnerships with cultivation facilities, research institutions, and distribution networks. Timeline: 12-24 months.
- Product Diversification: Expanding the product line beyond clones and calming pet products can reduce the company's reliance on specific market segments. This includes developing new cannabis-based products, such as edibles, topicals, and concentrates. Timeline: 18-36 months.
- Online Marketing and E-commerce: Investing in online marketing and e-commerce capabilities can enhance the company's brand visibility and reach a wider customer base. This includes optimizing the mycbdpets.com platform for online sales and implementing targeted advertising campaigns. The e-commerce cannabis market is projected to grow significantly in the coming years. Timeline: Ongoing.
Oportunidades
- Expansion into new geographic markets.
- Increased adoption of calming pet products.
- Strategic partnerships with established cannabis companies.
Amenazas
- Regulatory changes in the cannabis industry.
- Increasing competition from larger cannabis companies.
- Fluctuations in the price of cannabis.
Ventajas competitivas
- Brand recognition within the niche market of marijuana clones.
- Proprietary cultivation techniques for producing high-quality clones.
- Established online platform for selling calming pet products.
Acerca de ACCR
Founded in 1996, Access-Power & Co., Inc. is a Michigan-based company specializing in the medical marijuana clone market. The company manufactures and distributes medical marijuana clones under the brand names Clones By Drones and Clones by Cars. These products are targeted towards medical marijuana growers and dispensaries. In addition to its core marijuana clone business, Access-Power & Co., Inc. also offers calming pet products through its online platform, mycbdpets.com, diversifying its product line within the broader wellness market. The company operates with a small team, reflecting its early-stage nature and focus on niche markets within the cannabis industry.
Qué hacen
- Manufactures medical marijuana clones.
- Distributes clones under the Clones By Drones brand.
- Distributes clones under the Clones By Cars brand.
- Offers calming pet products through mycbdpets.com.
- Operates in the cannabis industry.
- Focuses on niche markets within the cannabis sector.
Modelo de Negocio
- Manufacturing and selling medical marijuana clones to growers and dispensaries.
- Selling calming pet products directly to consumers through an online platform.
- Generating revenue through product sales.
Contexto de la Industria
Access-Power & Co., Inc. operates within the evolving telecommunications services sector, specifically focusing on the niche market of medical marijuana clones and related products. The cannabis industry is characterized by rapid growth, regulatory changes, and increasing competition. While the telecommunications sector is broad, Access-Power's focus on specialized products differentiates it. The company's success depends on navigating regulatory hurdles, establishing brand recognition, and scaling operations effectively in a competitive landscape that includes both established players and emerging startups.
Clientes Clave
- Medical marijuana growers.
- Medical marijuana dispensaries.
- Pet owners seeking calming products.
Finanzas
Gráfico e información
Precio de la acción de Access-Power & Co., Inc. (ACCR): Price data unavailable
Últimas noticias
-
Stocks That Hit 52-Week Lows On Tuesday
· 24 mar 2020
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para ACCR.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para ACCR.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de ACCR en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: Patrick J. Jensen
Unknown
Patrick J. Jensen serves as the CEO of Access-Power & Co., Inc. Information regarding his detailed career history, educational background, and previous roles is not available. As the leader of a small company with only one employee, Jensen's role likely encompasses a wide range of responsibilities, from strategic planning to day-to-day operations.
Historial: Due to limited information, it is difficult to assess Patrick J. Jensen's track record at Access-Power & Co., Inc. The company's current financial state, characterized by a negative P/E ratio and small market capitalization, suggests significant challenges. However, the gross margin of 59.0% indicates potential for improvement under his leadership.
Información del mercado OTC de ACCR
The OTC Other tier represents the lowest tier of the OTC market, indicating that Access-Power & Co., Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQB or OTCQX. Companies in this tier often have limited trading volume and may not be required to provide regular financial reports, increasing the risk for investors compared to companies listed on major exchanges like NYSE or NASDAQ.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure increases information asymmetry and makes it difficult to assess the company's true financial health.
- Low trading volume and liquidity can lead to significant price volatility and difficulty in exiting positions.
- The OTC Other tier has fewer regulatory requirements, increasing the risk of fraud or mismanagement.
- The company's small size and limited resources may hinder its ability to compete effectively in the market.
- The cannabis industry is subject to evolving regulations, which can impact the company's operations and profitability.
- Verify the company's registration and legal standing with the relevant authorities.
- Review any available financial statements and assess the company's financial health.
- Research the company's management team and their experience in the industry.
- Understand the company's business model and competitive landscape.
- Assess the liquidity and trading volume of the stock.
- Be aware of the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- The company has been in operation since 1996, suggesting some level of stability.
- The company has a registered business address in Grand Haven, Michigan.
- The company has a website (mycbdpets.com) for its pet calming products.
Acciones de Access-Power & Co., Inc.: Preguntas Clave Respondidas
¿Cuáles son los factores clave para evaluar ACCR?
Access-Power & Co., Inc. (ACCR) actualmente tiene una puntuación IA de 61/100, indicando puntuación moderada. Fortaleza clave: Niche market focus on medical marijuana clones.. Riesgo principal a monitorear: Potential: Regulatory changes in the cannabis industry that could restrict or prohibit the company's operations.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de ACCR?
ACCR actualmente puntúa 61/100 (Grado B) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de ACCR?
Los precios de ACCR se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre ACCR?
La cobertura de analistas para ACCR incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en ACCR?
Las categorías de riesgo para ACCR incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Regulatory changes in the cannabis industry that could restrict or prohibit the company's operations.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de ACCR?
La relación P/E para ACCR compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está ACCR sobrevalorada o infravalorada?
Determinar si Access-Power & Co., Inc. (ACCR) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de ACCR?
Access-Power & Co., Inc. (ACCR) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Limited information available on the company's financials and operations.
- The company's OTC listing and small market capitalization increase investment risk.
- The cannabis industry is subject to evolving regulations.